Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIVJ. Medraño, Vincent Soriano, Salvador Resino et al.|Clinical Infectious Diseases|2010Cited by 57
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA loadKarin Neukam, Juan A. Pineda, Ángela Camacho et al.|Journal of Hepatology|2011Cited by 43